Pharmaceutical formulation comprising Levothyroxine Sodium, microcrystalline Cellulose, pregelatinised Starch, use thereof for the manufacture of a Medicament, and a process for preparing Said formulation

摘要

Stable drug formulations include: (a) effective levotiroxina sodium; (b) microcrystalline cellulose with an average particle size of less than 125 microns and 60-85% P / P in the total weight of the preparation; and (c) pre coagulated starch in a certain amount of pre coagulated starch. 5% to 30% P / W of the total weight of the preparation: use drug preparation to treat thyroid hormone disorders, and prepare this drug to mammals as human beings,I need it. 2. Includes (a) the preparation of a pharmaceutical formulation for a broken portion of levotiroxina sodium; (b) mixing the comminution with other components of the pharmaceutical formulation; and (c) understanding the mixture obtained from (b).